E-LIB Suche - Ergebnisse für: Forman, Seth

1

ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic De..:

Changelian, Paul ; Xu, Canxin ; Mnich, Steve...
JID Innovations. 4 (2024) 2 - p. 100251 , 2024

2

Importance of treating acne sequelae in skin of color: 6‐mo..:

Alexis, Andrew ; Del Rosso, James Q. ; Forman, Seth...
International Journal of Dermatology. 63 (2024) 6 - p. 806-815 , 2024

Link: https://doi.org/10.1111/..

3

493 - Lebrikizumab does not impact vaccine-induced immune r..:

Soung, Jennifer ; Laquer, Vivian ; Merola, Joseph F...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii3-ii3 , 2024

Link: https://doi.org/10.1093/..

4

Scalp, eyebrow, and eyelash hair regrowth with continued ri..:

Senna, Maryanna ; Forman, Seth ; Bordone, Lindsey...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 4 - p. s224 , 2023

Link: https://doi.org/10.25251..

5

Efficacy and Safety of Roflumilast Foam 0.3% in Patients Wi..:

Blauvelt, Andrew ; Alonso-Llamazares, Javier ; Bhatia, Neal...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s196 , 2023

Link: https://doi.org/10.25251..

6

42004 Scalp, eyebrow, and eyelash hair regrowth with contin..:

Senna, Maryanne ; Forman, Seth ; Bordone, Lindsey...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB221 , 2023

Link: https://doi.org/10.1016/..

7

Long-Term Safety and Disease Control of Ruxolitinib Cream A..:

Eichenfeld, Lawrence ; Simpson, Eric ; Papp, Kim...
SKIN The Journal of Cutaneous Medicine. 6 (2022) 2 - p. s28 , 2022

Link: https://doi.org/10.25251..

8

The contribution of itch and skin severity improvements to ..:

Yosipovitch, Gil ; Papp, Kim ; Forman, Seth...
British Journal of Dermatology. 186 (2022) 6 - p. 1047-1049 , 2022

Link: https://doi.org/10.1111/..

9

Durability of Response to Abrocitinib in Patients with Mode..:

Gooderham, Melinda J. ; Girolomoni, Giampiero ; Moore, Julian O....
Dermatology and Therapy. 12 (2022) 9 - p. 2077-2085 , 2022

Link: https://doi.org/10.1007/..

10

25447 Baricitinib treatment results in clinically meaningfu..:

Kwatra, Shawn ; Forman, Seth ; Cruz, Alma...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB59 , 2021

Link: https://doi.org/10.1016/..

11

Comparing Abrocitinib and Dupilumab in the Treatment of Ato..:

Bieber, Thomas ; Simpson, Eric L ; Silverberg, Jonathan I...
Immunotherapy. 14 (2021) 1 - p. 5-14 , 2021

Link: https://doi.org/10.2217/..

12

Efficacy and safety of the oral Janus kinase inhibitor bari..:

King, Brett ; Ko, Justin ; Forman, Seth...
Journal of the American Academy of Dermatology. 85 (2021) 4 - p. 847-853 , 2021

Link: https://doi.org/10.1016/..

13

27550 Durability of response to abrocitinib in patients wit..:

Gooderham, Melinda J. ; Girolomoni, Giampiero ; Moore, Julian O....
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB151 , 2021

Link: https://doi.org/10.1016/..

14

26670 The contribution of itch and skin severity improvemen..:

Yosipovitch, Gil ; Papp, Kim ; Forman, Seth...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB23 , 2021

Link: https://doi.org/10.1016/..

15

Long-Term Safety and Disease Control With Ruxolitinib Cream..:

Papp, Kim ; Szepietowski, Jacek ; Kircik, Leon...
SKIN The Journal of Cutaneous Medicine. 5 (2021) 6 - p. s63 , 2021

Link: https://doi.org/10.25251..